General Information of the Compound
| Compound ID |
CP0162622
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide;hydrochloride
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide
2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide
2-Butoxy-N-(beta.-diethylaminoethyl)cinchoninamide
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide
2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide
2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide
2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide
2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide
2-butoxy-N-(alpha-diethylaminoethyl)cinchoninamide
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
Alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine
Alpha-Butyloxycinchoninic acid diethylethylenediamide
Cincain (TN)
Cincainum
Cinchocaine
Cinchocaine (INN);Cinchocainum [INN-Latin]
Cinchocaine HCL
Cinchocaine hydrochloride
Cinchocainum
Cincocaina
Cincocaina [DCIT]
Cincocainio
Cincocainio [INN-Spanish]
Dermacaine
Dibucain
Dibucaine
Dibucaine (USP)
Dibucaine Base
Dibucaine [USP]
Dibucainum
N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide
N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide
Nupercainal
Nupercainal (TN)
Nupercainal (VAN)
Nupercaine
Nupercaine (TN)
Percamine
QUINOLINE,2-BUTOXY,4-CARBOXY,(N-TRIETHYLAMINO) AMIDE CINCHOCAIN
Sovcaine
Sovcaine (TN)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H29N3O2
|
||||||||||||||||||
| Molecular Weight |
343.471
|
||||||||||||||||||
| Canonical SMILES |
CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PUFQVTATUTYEAL-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
85-79-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound